Fact checked byErik Swain

Read more

December 21, 2022
1 min read
Save

FDA designates intra-aortic balloon pump recall as class I

Fact checked byErik Swain
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Arrow International announced it is recalling its intra-aortic balloon pumps after receiving complaints about shorter than expected battery power.

The FDA identified the recall of these devices (Arrow AutoCAT 2 and AC3) as class I, the most serious type of recall.

Recall_86693876
Arrow International announced it is recalling its intra-aortic balloon pumps after receiving complaints about shorter than expected battery power.
Source: Adobe Stock

A fully charged battery should last 90 minutes; however, multiple users have reported shorter battery life, according to a press release from the FDA.

In addition, the battery life warnings — designed to sound at 20, 10 and 5 minutes of power remaining — are inaccurate, according to the release.

If operated on battery power alone, the pump may suddenly stop mechanical support to the patient’s heart, potentially leading to cardiac arrest, stroke or death, according to the release.

The recall affects 2,132 devices distributed between July 1, 2022 and Sept. 30, 2022.

There have been 241 complaints reported with 135 instances of the pumps stopping. No deaths have been reported related to this issue.